Regarding epistaxis in the setting of antithrombotic therapy: A comparison between factor Xa inhibitors, warfarin, and antiplatelet agents
- PMID: 30724350
- DOI: 10.1002/lary.27824
Regarding epistaxis in the setting of antithrombotic therapy: A comparison between factor Xa inhibitors, warfarin, and antiplatelet agents
Comment in
-
In response to Epistaxis in the setting of antithrombotic therapy: A comparison between factor Xa inhibitors, warfarin, and antiplatelet agents.Laryngoscope. 2019 May;129(5):E161. doi: 10.1002/lary.27817. Epub 2019 Feb 6. Laryngoscope. 2019. PMID: 30724345 No abstract available.
Comment on
-
Epistaxis in the setting of antithrombotic therapy: A comparison between factor Xa inhibitors, warfarin, and antiplatelet agents.Laryngoscope. 2019 Jan;129(1):119-123. doi: 10.1002/lary.27400. Epub 2018 Oct 16. Laryngoscope. 2019. PMID: 30325496
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical